CURX

CURANEX PHARMACEUTICALS INC

0.4370

-0.0061-1.38%

After Hours: 0.4293 -0.0077 -1.76%19:49 04/24 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.4101/0.4170

TODAY RANGE0.3814-0.4101

VOL198.63K

MARKET CAP11.30M

52 WEEK RANGE0.2620-9.18

AVG VOL (3M)4.32M

% TURNOVER0.70%

TURNOVER--

P/E (TTM)-2.4049

% RANGE6.88%

EPS(TTM)-0.1657

P/E(FORWARD)--

P/B1.007

BVPS0.3959

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.64M

SHARES OUTSTANDING28.36M

NEXT EARNINGS--

FREE FLOAT9.15M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·04/06 15:16
Curanex Showcases Patient Case Study Highlighting Potential Of Phyto-N; Stock Up
TipRanks·04/06 13:58
Curanex highlights patient case study in treatment of cancer cachexia
Reuters·04/06 13:17
Curanex highlights Phyto-N case study supporting potential cancer cachexia supportive-care use
TipRanks·04/02 13:20
Curanex Adds Cancer Cachexia to Core Drug Pipeline
Reuters·04/02 12:22
CURANEX PHARMACEUTICALS INC - TO FOCUS ON CANCER CACHEXIA AS NEW CORE INDICATION - SEC FILING
Reuters·04/02 12:08
Curanex targets cancer cachexia in pipeline expansion to broaden therapeutics focus
Reuters·03/19 00:43
Curanex Phyto-N repeat-dose study shows no toxicology findings at maximum feasible dose
TipRanks·03/18 12:17
Curanex completes dose-range finding toxicology study of Phyto-N
Reuters·03/18 12:05
Curanex reports no toxicology findings at maximum feasible dose in 28-day Phyto-N study
Reuters·03/18 12:04
CURANEX PHARMACEUTICALS INC - TARGETS IND SUBMISSION FOR PHYTO-N IN Q4 2026
Reuters·03/12 13:30
Curanex appoints Taku Kambayashi and Selvakumar Subbian to scientific advisory board
Reuters·03/12 13:30
CURANEX EXPANDS SCIENTIFIC ADVISORY BOARD WITH TWO DISTINGUISHED RESEARCHERS
TipRanks·03/11 12:23
Curanex appoints two research experts to board of directors
Reuters·03/11 12:03
Curanex appoints Daniel Pascheles and Nicholas Meanwell to scientific advisory board
Reuters·03/11 12:00
CURANEX APPOINTS TWO VETERAN INDUSTRY LEADERS TO SCIENTIFIC ADVISORY BOARD

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-0.95%

744.44

GridAI Tech

GRDX

-1.79%

2.200

BNTX

UTHR

VRTX

SIGA

Moderna

MRNA

-3.28%

49.07

CRL

Medpace Holdings

MEDP

+4.35%

410.54

Talphera Inc

TLPH

+3.46%

0.7646

ICON PLC

ICLR

-3.92%

102.17

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-2.97%

158.98

MOLECULAR PARTNERS AG

MOLN

-2.46%

4.350

Arcturus Therape

ARCT

+1.42%

8.59

Gilead Sciences Inc

GILD

-2.42%

130.40

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

+2.12%

97.74

Aptevo Therapeutics Inc

APVO

-0.30%

4.905

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.